\-\ Texto\\:\\ \ \(0\)\
\-\ results\\ of\\ treatment\\ of\\ esophageal\\ cancer\\ are\\ disappointing\\.\\ a\\ large\\ percentage\\ of\\ patients\\ are\\ inoperable\\ at\\ presentation\\.\\ chemotherapy\\ is\\ essentially\\ not\\ effective\\.\\ radiation\\ therapy\\ has\\ been\\ used\\ successfully\\ for\\ palliation\\ and\\ occasionally\\ is\\ curative\\.\\ cancer\\ of\\ the\\ lower\\ one\\-third\\ of\\ the\\ esophagus\\ leads\\ itself\\ most\\ readily\\ to\\ surgical\\ resection\\.\\ prior\\ to\\ tumor\\ resection\\,\\ intra\\-operative\\ evaluation\\ is\\ made\\ for\\ involvement\\ of\\ celiac\\ and\\ periaortic\\ nodes\\ as\\ well\\ as\\ for\\ liver\\ metastasis\\.\\ if\\ these\\ structures\\ are\\ involved\\,\\ no\\ resection\\ is\\ attempted\\.\\ if\\ resection\\ is\\ attempted\\,\\ the\\ extent\\ of\\ the\\ resection\\ may\\ physically\\ prevent\\ re\\-anastamosis\\ necessitating\\ the\\ use\\ of\\ a\\ colon\\ transplant\\.\ \(0\)\
\-\ the\\ pa\\ film\\ shows\\ multiple\\ irregular\\ filling\\ defects\\ involving\\ a\\ large\\ portion\\ of\\ the\\ distal\\ esophagus\\ and\\ the\\ fundus\\ of\\ the\\ stomach\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ gastro\\-esophageal\\ junction\ \(0\)\
\-\ 39\\ y\\.o\\.\\ white\\ male\\ with\\ progressive\\ dysphagia\\,\\ first\\ to\ \(1\)\
\-\ solids\\,\\ then\\ to\\ liquids\ \(1\)\
\-\ pathology\\:\\ cancer\\ of\\ the\\ gastro\\-esophageal\\ junction\\ can\\ be\\ either\\ a\\ primary\\ esophageal\\ cancer\\ invading\\ into\\ the\\ fundus\\ of\\ the\\ stomach\\ or\\ a\\ primary\\ gastric\\ carcinoma\\ originating\\ in\\ the\\ fundus\\ and\\ extending\\ into\\ the\\ lower\\ esophagus\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ esophagus\\ is\\ most\\ commonly\\ squamous\\ cell\\ carcinoma\\.\\ distribution\\ tends\\ to\\ be\\ middle\\>lower\\>upper\\ third\\ of\\ the\\ esophagus\\.\\ males\\ tend\\ to\\ develop\\ it\\ four\\ times\\ as\\ frequently\\ as\\ females\\;\\ however\\,\\ the\\ upper\\ esophagus\\ is\\ involved\\ ten\\ times\\ as\\ frequently\\ in\\ females\\ \\(thought\\ to\\ be\\ due\\ to\\ plummer\\-vinson\\ syndrome\\)\\.\\ the\\ second\\ most\\ common\\ are\\ adenocarcinomas\\ which\\ tend\\ to\\ be\\ in\\ the\\ lower\\ esophagus\\.\\ they\\ very\\ rarely\\ arise\\ from\\ esophageal\\ submucosal\\ glands\\.\\ rather\\,\\ they\\ tend\\ to\\ be\\ an\\ invading\\ gastric\\ adenocarcinoma\\ or\\ an\\ adenocarcinoma\\ arising\\ from\\ the\\ columnar\\ cells\\ of\\ a\\ barrett\\'s\\ esophagus\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ stomach\\ is\\ typically\\ an\\ adenocarcinoma\\.\\ they\\ most\\ commonly\\ \\(50\\%\\)\\ occur\\ in\\ the\\ antrum\\ of\\ the\\ stomach\\ but\\ 10\\%\\ do\\ tend\\ to\\ arise\\ in\\ the\\ fundus\\.\\ the\\ incidence\\ rate\\ is\\ slightly\\ higher\\ for\\ males\\ than\\ females\\.\ \(0\)\
\-\ risk\\ factors\\:\\ the\\ overall\\ incidence\\ rate\\ in\\ the\\ us\\ for\\ esophageal\\ cancer\\ and\\ for\\ gastric\\ cancer\\ are\\ similar\\ \\(10\\/100\\,000\\)\\.\\ the\\ rates\\ tend\\ to\\ be\\ much\\ higher\\ in\\ japan\\ and\\ china\\.\\ aside\\ from\\ barrett\\'s\\ esophagus\\,\\ esophageal\\ cancer\\ is\\ associated\\ with\\ tobacco\\ use\\ \\(smoked\\ and\\ chewed\\)\\,\\ poor\\ dentition\\,\\ and\\ alcohol\\ abuse\\.\\ the\\ etiology\\ of\\ gastric\\ cancer\\ is\\ more\\ mysterious\\ but\\ is\\ thought\\ to\\ be\\ an\ \(0\)\
\-\ environmental\\ or\\ dietary\\ factor\\.\\ in\\ addition\\,\\ achlorhydria\\,\\ pernicious\\ anemia\\,\\ and\\ atrophic\\ gastritis\\ have\\ been\\ shown\\ to\\ be\\ risks\\ for\\ gastric\\ cancer\\.\ \(0\)\
\-\ clinical\\ presentation\\:\\ tumors\\ of\\ the\\ esophago\\-gastric\\ junction\\ most\\ commonly\\ present\\ with\\ dysphagia\\ which\\ may\\ be\\ accompanied\\ with\\ a\\ sensation\\ of\\ substernal\\ fulness\\.\\ there\\ may\\ or\\ may\\ not\\ be\\ pain\\.\\ dysphagia\\ is\\ typically\\ with\\ solid\\ food\\ first\\ but\\ later\\ involve\\ soft\\ food\\ and\\ liquids\\.\\ if\\ the\\ lumen\\ should\\ become\\ obstructed\\,\\ the\\-\\ patient\\ becomes\\ unable\\ to\\ swallow\\ his\\ own\\ saliva\\ leading\\ to\\ constant\\ drooling\\.\\ weight\\ loss\\ commonly\\ occurs\\ in\\ later\\ stages\\ of\\ the\\ disease\\ leading\\ to\\ severe\\ emaciation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cancer\\:\\ 0\\.06384466509919921\ \(0\)\
\-\ esophagus\\:\\ 0\\.06323135710339632\ \(0\)\
\-\ tend\\:\\ 0\\.04588282680316645\ \(0\)\
\-\ fundus\\:\\ 0\\.03745695009892885\ \(0\)\
\-\ esophageal\\:\\ 0\\.037099229394087\ \(0\)\
\-\ gastric\\:\\ 0\\.036158202179946815\ \(0\)\
\-\ stomach\\:\\ 0\\.028625498648127797\ \(0\)\
\-\ females\\:\\ 0\\.027017473939886814\ \(0\)\
\-\ gastro\\-esophageal\\:\\ 0\\.02602124346557267\ \(0\)\
\-\ resection\\:\\ 0\\.02523594370757783\ \(0\)\
\-\ be\\:\\ 0\\.02495751369969563\ \(0\)\
\-\ barrett\\:\\ 0\\.02467020201125929\ \(0\)\
\-\ commonly\\:\\ 0\\.024428268511027588\ \(0\)\
\-\ dysphagia\\:\\ 0\\.023645216328460086\ \(0\)\
\-\ liquids\\:\\ 0\\.023395685963451665\ \(0\)\
\-\ invading\\:\\ 0\\.021515243212262686\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.020974741162291134\ \(0\)\
\-\ junction\\:\\ 0\\.02033566171100312\ \(0\)\
\-\ food\\:\\ 0\\.018728475049464424\ \(0\)\
\-\ most\\:\\ 0\\.018682150963334053\ \(0\)\
\-\ males\\:\\ 0\\.018650371688848\ \(0\)\
\-\ attempted\\:\\ 0\\.01807752710656041\ \(0\)\
\-\ they\\:\\ 0\\.01749401208231424\ \(0\)\
\-\ re\\-anastamosis\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ plummer\\-vinson\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ 10\\/100\\,000\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ mysterious\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ achlorhydria\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ esophago\\-gastric\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ fulness\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ the\\-\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ emaciation\\:\\ 0\\.01669605762114867\ \(0\)\
\-\ arise\\:\\ 0\\.016024814186726993\ \(0\)\
\-\ higher\\:\\ 0\\.015873278828341768\ \(0\)\
\-\ times\\:\\ 0\\.015692006020850725\ \(0\)\
\-\ leading\\:\\ 0\\.015485343201720294\ \(0\)\
\-\ china\\:\\ 0\\.015383278870088168\ \(0\)\
\-\ chewed\\:\\ 0\\.015383278870088168\ \(0\)\
\-\ thought\\:\\ 0\\.014896653414318664\ \(0\)\
\-\ incidence\\:\\ 0\\.014839691757634799\ \(0\)\
\-\ disappointing\\:\\ 0\\.01461535252897422\ \(0\)\
\-\ inoperable\\:\\ 0\\.01461535252897422\ \(0\)\
\-\ pernicious\\:\\ 0\\.01461535252897422\ \(0\)\
\-\ lower\\:\\ 0\\.014559561131544415\ \(0\)\
\-\ may\\:\\ 0\\.014199457340137302\ \(0\)\
\-\ environmental\\:\\ 0\\.014070500119027666\ \(0\)\
\-\ frequently\\:\\ 0\\.014028525134886194\ \(0\)\
\-\ is\\:\\ 0\\.013844280528411804\ \(0\)\
\-\ to\\:\\ 0\\.013750298946080996\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.013647879756690148\ \(0\)\
\-\ involved\\:\\ 0\\.013577309875423908\ \(0\)\
\-\ columnar\\:\\ 0\\.013302573777913718\ \(0\)\
\-\ if\\:\\ 0\\.013174678601026339\ \(0\)\
\-\ intra\\-operative\\:\\ 0\\.013010621732786335\ \(0\)\
\-\ physically\\:\\ 0\\.013010621732786335\ \(0\)\
\-\ japan\\:\\ 0\\.013010621732786335\ \(0\)\
\-\ use\\:\\ 0\\.012793329981224632\ \(0\)\
\-\ palliation\\:\\ 0\\.012757721367967163\ \(0\)\
\-\ periaortic\\:\\ 0\\.012757721367967163\ \(0\)\
\-\ saliva\\:\\ 0\\.012757721367967163\ \(0\)\
\-\ rate\\:\\ 0\\.012616369282105466\ \(0\)\
\-\ necessitating\\:\\ 0\\.012335101005629645\ \(0\)\
\-\ smoked\\:\\ 0\\.012335101005629645\ \(0\)\
\-\ as\\:\\ 0\\.012240317290664089\ \(0\)\
\-\ dentition\\:\\ 0\\.011989795026853215\ \(0\)\
\-\ drooling\\:\\ 0\\.011989795026853215\ \(0\)\
\-\ gastritis\\:\\ 0\\.01183819898959273\ \(0\)\
\-\ later\\:\\ 0\\.011687191821942894\ \(0\)\
\-\ one\\-third\\:\\ 0\\.011567174664515697\ \(0\)\
\-\ typically\\:\\ 0\\.011425855187522623\ \(0\)\
\-\ aside\\:\\ 0\\.011330123257405837\ \(0\)\
\-\ percentage\\:\\ 0\\.011221868685739269\ \(0\)\
\-\ solids\\:\\ 0\\.011221868685739269\ \(0\)\
\-\ ten\\:\\ 0\\.011221868685739269\ \(0\)\
\-\ substernal\\:\\ 0\\.011221868685739269\ \(0\)\
\-\ presentation\\:\\ 0\\.011149244827617737\ \(0\)\
\-\ are\\:\\ 0\\.011031002580772744\ \(0\)\
\-\ readily\\:\\ 0\\.010929916640611884\ \(0\)\
\-\ atrophic\\:\\ 0\\.010929916640611884\ \(0\)\
\-\ first\\:\\ 0\\.010861679677219137\ \(0\)\
\-\ curative\\:\\ 0\\.010841810550394284\ \(0\)\
\-\ dietary\\:\\ 0\\.010841810550394284\ \(0\)\
\-\ \\>\\:\\ 0\\.010754422404047594\ \(0\)\
\-\ tends\\:\\ 0\\.010677016275792713\ \(0\)\
\-\ obstructed\\:\\ 0\\.010525420238532228\ \(0\)\
\-\ risks\\:\\ 0\\.01045394234462532\ \(0\)\
\-\ own\\:\\ 0\\.01038506423066533\ \(0\)\
\-\ but\\:\\ 0\\.010355132392236009\ \(0\)\
\-\ submucosal\\:\\ 0\\.010254395913455195\ \(0\)\
\-\ antrum\\:\\ 0\\.010254395913455195\ \(0\)\
\-\ celiac\\:\\ 0\\.009962443868327812\ \(0\)\
\-\ accompanied\\:\\ 0\\.009962443868327812\ \(0\)\
\-\ constant\\:\\ 0\\.009857197938110367\ \(0\)\
\-\ successfully\\:\\ 0\\.009806689894394153\ \(0\)\
\-\ tobacco\\:\\ 0\\.009757493897418281\ \(0\)\
\-\ stages\\:\\ 0\\.00970954350350864\ \(0\)\
\-\ for\\:\\ 0\\.009666206516096601\ \(0\)\
\-\ originating\\:\\ 0\\.009662777191784452\ \(0\)\
\-\ glands\\:\\ 0\\.009617137889551382\ \(0\)\
\-\ primary\\:\\ 0\\.009588576753392789\ \(0\)\
\-\ swallow\\:\\ 0\\.009444842855070839\ \(0\)\
\-\ rates\\:\\ 0\\.009404111405788711\ \(0\)\
\-\ abuse\\:\\ 0\\.009404111405788711\ \(0\)\
\-\ effective\\:\\ 0\\.009212641487471725\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009173968447029798\ \(0\)\
\-\ itself\\:\\ 0\\.009106411436996264\ \(0\)\
\-\ essentially\\:\\ 0\\.009072285479604827\ \(0\)\
\-\ leads\\:\\ 0\\.009038763553280205\ \(0\)\
\-\ an\\:\\ 0\\.00895200654761159\ \(0\)\
\-\ transplant\\:\\ 0\\.008941617162394694\ \(0\)\
\-\ been\\:\\ 0\\.008806041247969664\ \(0\)\
\-\ the\\:\\ 0\\.008640580293976612\ \(0\)\
\-\ occasionally\\:\\ 0\\.008518996800057174\ \(0\)\
\-\ becomes\\:\\ 0\\.008469153413092451\ \(0\)\
\-\ factor\\:\\ 0\\.008259793802486724\ \(0\)\
\-\ alcohol\\:\\ 0\\.008152763101230396\ \(0\)\
\-\ develop\\:\\ 0\\.008071290780996132\ \(0\)\
\-\ overall\\:\\ 0\\.00805145877367171\ \(0\)\
\-\ anemia\\:\\ 0\\.00805145877367171\ \(0\)\
\-\ extent\\:\\ 0\\.008031832283074082\ \(0\)\
\-\ prevent\\:\\ 0\\.008031832283074082\ \(0\)\
\-\ squamous\\:\\ 0\\.007918161810107694\ \(0\)\
\-\ upper\\:\\ 0\\.00781091100518454\ \(0\)\
\-\ lumen\\:\\ 0\\.007793632685935761\ \(0\)\
\-\ rarely\\:\\ 0\\.007759506728544325\ \(0\)\
\-\ become\\:\\ 0\\.0077094437416728185\ \(0\)\
\-\ into\\:\\ 0\\.007701993818029193\ \(0\)\
\-\ rather\\:\\ 0\\.007693045895568435\ \(0\)\
\-\ involve\\:\\ 0\\.00762883841133419\ \(0\)\
\-\ or\\:\\ 0\\.00758729355275536\ \(0\)\
\-\ \\%\\:\\ 0\\.007550458459643968\ \(0\)\
\-\ 39\\:\\ 0\\.007521460866492248\ \(0\)\
\-\ much\\:\\ 0\\.007491867461372777\ \(0\)\
\-\ unable\\:\\ 0\\.007477242374073705\ \(0\)\
\-\ defects\\:\\ 0\\.0074340327570923195\ \(0\)\
\-\ sensation\\:\\ 0\\.0074340327570923195\ \(0\)\
\-\ nodes\\:\\ 0\\.007310021527206889\ \(0\)\
\-\ distribution\\:\\ 0\\.007283532432557761\ \(0\)\
\-\ poor\\:\\ 0\\.007283532432557761\ \(0\)\
\-\ factors\\:\\ 0\\.0072704255332309165\ \(0\)\
\-\ from\\:\\ 0\\.0071956574611034795\ \(0\)\
\-\ in\\:\\ 0\\.007182907331936163\ \(0\)\
\-\ \\,\\:\\ 0\\.007177918403867468\ \(0\)\
\-\ \\'s\\:\\ 0\\.007136540221087292\ \(0\)\
\-\ large\\:\\ 0\\.007077812241784393\ \(0\)\
\-\ either\\:\\ 0\\.007048803452954046\ \(0\)\
\-\ four\\:\\ 0\\.007025706344821814\ \(0\)\
\-\ do\\:\\ 0\\.007025706344821814\ \(0\)\
\-\ addition\\:\\ 0\\.006860912070220242\ \(0\)\
\-\ etiology\\:\\ 0\\.006850419304357334\ \(0\)\
\-\ us\\:\\ 0\\.006788654937711954\ \(0\)\
\-\ pa\\:\\ 0\\.0067685064562629845\ \(0\)\
\-\ arising\\:\\ 0\\.006699628342302995\ \(0\)\
\-\ occurs\\:\\ 0\\.006642520315464571\ \(0\)\
\-\ pathology\\:\\ 0\\.006623860663110382\ \(0\)\
\-\ slightly\\:\\ 0\\.006542095186092941\ \(0\)\
\-\ results\\:\\ 0\\.006533224259364861\ \(0\)\
\-\ filling\\:\\ 0\\.006515606091443813\ \(0\)\
\-\ third\\:\\ 0\\.006489482375284086\ \(0\)\
\-\ cells\\:\\ 0\\.006489482375284086\ \(0\)\
\-\ shown\\:\\ 0\\.006489482375284086\ \(0\)\
\-\ irregular\\:\\ 0\\.006455201993383295\ \(0\)\
\-\ solid\\:\\ 0\\.006455201993383295\ \(0\)\
\-\ made\\:\\ 0\\.006446727977483822\ \(0\)\
\-\ \\:\\:\\ 0\\.006422015999946961\ \(0\)\
\-\ progressive\\:\\ 0\\.006396664990612316\ \(0\)\
\-\ colon\\:\\ 0\\.006355933541330188\ \(0\)\
\-\ similar\\:\\ 0\\.006347891323751682\ \(0\)\
\-\ structures\\:\\ 0\\.006231184630368778\ \(0\)\
\-\ film\\:\\ 0\\.006216153286437458\ \(0\)\
\-\ second\\:\\ 0\\.006216153286437458\ \(0\)\
\-\ used\\:\\ 0\\.006208682115431746\ \(0\)\
\-\ 50\\:\\ 0\\.006157193213340539\ \(0\)\
\-\ tumors\\:\\ 0\\.006079008253163828\ \(0\)\
\-\ occur\\:\\ 0\\.006072058009055944\ \(0\)\
\-\ metastasis\\:\\ 0\\.00605823357253774\ \(0\)\
\-\ which\\:\\ 0\\.006042214345615715\ \(0\)\
\-\ involvement\\:\\ 0\\.005931702001189047\ \(0\)\
\-\ middle\\:\\ 0\\.005918861684928859\ \(0\)\
\-\ very\\:\\ 0\\.005874593974350624\ \(0\)\
\-\ portion\\:\\ 0\\.005862133801816452\ \(0\)\
\-\ risk\\:\\ 0\\.005862133801816452\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.005801033683978911\ \(0\)\
\-\ weight\\:\\ 0\\.005801033683978911\ \(0\)\
\-\ then\\:\\ 0\\.005759406966708504\ \(0\)\
\-\ involving\\:\\ 0\\.005678801636369875\ \(0\)\
\-\ liver\\:\\ 0\\.005579964982637734\ \(0\)\
\-\ \\(\\:\\ 0\\.005472437320029246\ \(0\)\
\-\ 10\\:\\ 0\\.005455727705202482\ \(0\)\
\-\ extending\\:\\ 0\\.005440755774317798\ \(0\)\
\-\ \\)\\:\\ 0\\.005405588576615948\ \(0\)\
\-\ white\\:\\ 0\\.005367621614984882\ \(0\)\
\-\ radiation\\:\\ 0\\.00531108191204988\ \(0\)\
\-\ a\\:\\ 0\\.005257951918049638\ \(0\)\
\-\ should\\:\\ 0\\.005159485874789394\ \(0\)\
\-\ clinical\\:\\ 0\\.004979753409215917\ \(0\)\
\-\ severe\\:\\ 0\\.004979753409215917\ \(0\)\
\-\ of\\:\\ 0\\.004854325033249517\ \(0\)\
\-\ evaluation\\:\\ 0\\.004701209840581076\ \(0\)\
\-\ loss\\:\\ 0\\.004697848811493256\ \(0\)\
\-\ not\\:\\ 0\\.004677343453567937\ \(0\)\
\-\ y\\.o\\:\\ 0\\.004671173167777841\ \(0\)\
\-\ his\\:\\ 0\\.004664562552361614\ \(0\)\
\-\ syndrome\\:\\ 0\\.0046286109407853064\ \(0\)\
\-\ however\\:\\ 0\\.00450637889317627\ \(0\)\
\-\ shows\\:\\ 0\\.004449571401001664\ \(0\)\
\-\ distal\\:\\ 0\\.004400148842700809\ \(0\)\
\-\ cell\\:\\ 0\\.004371668014358876\ \(0\)\
\-\ therapy\\:\\ 0\\.004326971205001161\ \(0\)\
\-\ due\\:\\ 0\\.004318706729077348\ \(0\)\
\-\ than\\:\\ 0\\.00424062283128461\ \(0\)\
\-\ common\\:\\ 0\\.004235354568099237\ \(0\)\
\-\ these\\:\\ 0\\.00421182706810197\ \(0\)\
\-\ patients\\:\\ 0\\.004188588256375049\ \(0\)\
\-\ prior\\:\\ 0\\.004155516614019628\ \(0\)\
\-\ more\\:\\ 0\\.004047682404000315\ \(0\)\
\-\ soft\\:\\ 0\\.003941149174230208\ \(0\)\
\-\ \\;\\:\\ 0\\.0038360249781299125\ \(0\)\
\-\ associated\\:\\ 0\\.0038190578824009508\ \(0\)\
\-\ tumor\\:\\ 0\\.0037731672378992637\ \(0\)\
\-\ can\\:\\ 0\\.003670875667555056\ \(0\)\
\-\ well\\:\\ 0\\.003661138168501233\ \(0\)\
\-\ present\\:\\ 0\\.0036553196097190927\ \(0\)\
\-\ it\\:\\ 0\\.0036379704252519256\ \(0\)\
\-\ have\\:\\ 0\\.0035046175726611587\ \(0\)\
\-\ and\\:\\ 0\\.003409261472201107\ \(0\)\
\-\ multiple\\:\\ 0\\.0034087234914380094\ \(0\)\
\-\ surgical\\:\\ 0\\.0034019351709307834\ \(0\)\
\-\ treatment\\:\\ 0\\.0032757896962138013\ \(0\)\
\-\ has\\:\\ 0\\.003039204489572496\ \(0\)\
\-\ male\\:\\ 0\\.0029265256399383962\ \(0\)\
\-\ disease\\:\\ 0\\.00264533625230247\ \(0\)\
\-\ there\\:\\ 0\\.0024085521902746\ \(0\)\
\-\ at\\:\\ 0\\.002192733243999305\ \(0\)\
\-\ \\.\\:\\ 0\\.002017019096440129\ \(0\)\
\-\ pain\\:\\ 0\\.001976530620323361\ \(0\)\
\-\ no\\:\\ 0\\.0016296290733026552\ \(0\)\
\-\ patient\\:\\ 0\\.001622333202493159\ \(0\)\
\-\ with\\:\\ 0\\.0011079940917603196\ \(0\)\
